Orthofix Medical Current Ratio

OFIX Stock

USD 12.35 0.20 1.65%

Orthofix Medical's latest Current Ratio figure appears below alongside the formula and what it measures. Understanding the formula helps clarify what this metric measures. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Current Ratio

Current Asset

Current Liabilities

3.15 X

Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least twice current liabilities (i.e., Current Ratio of 2 to 1). Orthofix Medical's Current Ratio reflects values from the latest available filings. All figures reflect reported accounting data.

Latest Orthofix Medical Current Ratio Growth Pattern

View

Last Reported 3.15 X

10 Years Trend

High Variability

Compare to Others All Financials

Current Ratio

Timeline

Current Ratio Trend Statistics

Orthofix Medical reports Current Ratio with a coefficient of variation of 25.6% over 15 periods, reflecting elevated dispersion relative to the mean. R-squared at 0.26 is consistent with a weak linear trend that explains limited variance.

	Arithmetic Mean	3.11
	Geometric Mean	3.02
	Coefficient Of Variation	25.56
	Mean Deviation	0.62
	Median	2.85
	Standard Deviation	0.79
	Sample Variance	0.63
	Range	2.642
	R-Value	-0.51
	Mean Square Error	0.50
	R-Squared	0.26
	Significance	0.04
	Slope	-0.08
	Total Sum of Squares	10.09

Orthofix Medical Current Ratio History

Reported values for Orthofix Medical's Current Ratio span 2012 to 2026 (15 observations), ranging from 4.95 to 3.39.

	2026	3.39
	2025	2.45
	2024	2.57
	2023	2.54
	2022	3.06
	2021	2.55
	2020	2.6
	2019	3.07
	2018	2.85
	2017	3.17
	2016	2.33
	2015	2.59
	2014	3.86
	2013	4.03
	2012	4.95

Correlation of Current Ratio With Other Accounts

Linear correlations between Current Ratio and other accounts within Orthofix Medical's reporting history are shown below. Strong correlations may reflect underlying operational relationships or scaling effects across related metrics.

Click cells to compare fundamentals

Related Fundamentals

	Last Reported	End Of Year Estimate
Other Current Liabilities	108.1 M	113.5 M
Total Current Liabilities	170.5 M	179 M
Non Current Assets Total	433.8 M	234.8 M
Non Current Assets Other	-77.4 M	-73.6 M
Non Current Liabilities Total	230.1 M	241.6 M
Other Current Assets	164.9 M	173.2 M
Total Current Assets	416.8 M	232.4 M
Current Deferred Revenue	-1.15	-1.09
Non Current Liabilities Other	55.7 M	42.6 M

Current Ratio Driver Correlations

The correlation data quantifies how Current Ratio at Orthofix Medical relates to other financial line items. These relationships describe association across reporting periods, not causation.

Competition

Current Ratio Over Time

Orthofix Discontinued Operations

Discontinued Operations

0.0

Discontinued Operations stood at 0.00 as of December 31, 2025.

Fundamental Drivers Relationships

Current Ratio stood at 3.39 as of December 31, 2025. Related reported metrics: Other Current Liab at 113.51 Million as of December 31, 2025; Total Current Liabilities at 179.01 Million as of December 31, 2025.

Current Ratio Peer Comparison

Comparing Orthofix Medical's Current Ratio to that of its competitors is a reliable method for assessing relative value. Comparing Orthofix Medical's Current Ratio to peer stocks determines whether it trades at a premium or discount. Tracking Orthofix Medical's Current Ratio rank within the peer group over time reveals shifts in competitive dynamics. The Current Ratio peer framework provides a practical lens for evaluating Orthofix Medical's relative standing.

Orthofix Medical is currently under evaluation in current ratio among leading competitors.

Important Fundamentals

	Return On Equity	-0.19
	Return On Asset	-0.0491
	Profit Margin	-0.11
	Operating Margin	-0.0127
	Current Valuation	584.16 M
	Shares Outstanding	40.14 M
	Shares Owned By Insiders	2.83 %
	Shares Owned By Institutions	90.04 %
	Number Of Shares Shorted	1.2 M
	Price To Earnings	338.00 X
	Price To Book	1.08 X
	Price To Sales	0.59 X
	Revenue	822.31 M
	Gross Profit	566.02 M
	EBITDA	-22.35 M
	Net Income	-92.19 M
	Cash And Equivalents	59.54 M
	Cash Per Share	2.98 X
	Total Debt	229.26 M
	Debt To Equity	0.08 %
	Current Ratio	3.15 X
	Book Value Per Share	11.30 X
	Cash Flow From Operations	33.35 M
	Short Ratio	4.28 X
	Earnings Per Share	-2.33 X
	Price To Earnings To Growth	8.10 X
	Target Price	17.25
	Number Of Employees	1.6 K
	Trailing Beta	0.82
	Market Capitalization	487.75 M
	Total Asset	850.65 M
	Retained Earnings	-368.33 M
	Working Capital	246.37 M
	Current Asset	147.87 M
	Current Liabilities	52.94 M
	Net Asset	850.65 M

Financial Metrics, Fundamentals & Methodology

The financial architecture of Orthofix Medical shows how effectively the business turns scale into retained value. Operating margins help show whether the business still holds structural pricing or cost advantages. Latest reported fundamentals for Orthofix Medical include revenue of 822.31 M, EPS loss of 2.33, negative operating margin of 1.27%, current ratio of 3.15 as of the latest reporting period.

Orthofix Medical inputs come from periodic company reporting and market reference feeds and are mapped into a consistent reporting framework. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.

Editorial review and methodology oversight provided by: Michael Smolkin, Member of Macroaxis Board of Directors

	Total Current Liabilities	Total Current Assets	Current Deferred Revenue	Current Ratio
Total Current Liabilities		0.77	-0.29	-0.61
Total Current Assets	0.77		-0.07	-0.39
Current Deferred Revenue	-0.29	-0.07		0.06
Current Ratio	-0.61	-0.39	0.06

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share
Price To Sales Ratio		0.83	0.33	-0.45	0.34	-0.06	0.83	0.98	0.31
Ptb Ratio	0.83		0.28	-0.32	0.51	0.0	1.0	0.88	0.52
Days Sales Outstanding	0.33	0.28		-0.44	0.1	0.19	0.28	0.34	-0.02
Book Value Per Share	-0.45	-0.32	-0.44		-0.02	0.29	-0.32	-0.35	0.12
Free Cash Flow Yield	0.34	0.51	0.1	-0.02		0.01	0.51	0.41	0.92
Capex To Depreciation	-0.06	0.0	0.19	0.29	0.01		0.0	-0.02	-0.03
Pb Ratio	0.83	1.0	0.28	-0.32	0.51	0.0		0.88	0.52
Ev To Sales	0.98	0.88	0.34	-0.35	0.41	-0.02	0.88		0.41
Free Cash Flow Per Share	0.31	0.52	-0.02	0.12	0.92	-0.03	0.52	0.41